Search research articles
Contact Us
Filters
Showing results (121-130 of 133) with videos related to
Page
of 14
Sort By:
Nature Medicine
|
October 10, 2018
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Rodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, et al.
Cancer Discovery
|
December 2, 2025
Editor's Note: Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
Pei-Ling Chen, Whijae Roh, Alexandre Reuben, et al.
Science (New York, N.Y.)
|
September 16, 2017
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T Geller, Michal Barzily-Rokni, Tal Danino, et al.
Cancer Immunology Research
|
January 20, 2022
Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16<sup>+</sup> Cancers
Lauren E Colbert, Molly B El, Erica J Lynn, et al.
Cancer Discovery
|
June 16, 2016
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
Pei-Ling Chen, Whijae Roh, Alexandre Reuben, et al.
Cancer Cell
|
May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception
Bo Zhu, Pingjun Chen, Muhammad Aminu, et al.
Nature
|
March 18, 2021
Identification of bacteria-derived HLA-bound peptides in melanoma
Shelly Kalaora, Adi Nagler, Deborah Nejman, et al.
Neuro-Oncology
|
March 22, 2025
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma
Patrick Y Wen, Andrea Manzanera, Caroline Duault, et al.
Nature Communications
|
February 1, 2020
Comprehensive T cell repertoire characterization of non-small cell lung cancer
Alexandre Reuben, Jiexin Zhang, Shin-Heng Chiou, et al.
NPJ Genomic Medicine
|
August 19, 2017
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma
Alexandre Reuben, Christine N Spencer, Peter A Prieto, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 133) with videos related to
Sort By:
Page
of 14
Nature Medicine
|
October 10, 2018
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Rodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, et al.
Cancer Discovery
|
December 2, 2025
Editor's Note: Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
Pei-Ling Chen, Whijae Roh, Alexandre Reuben, et al.
Science (New York, N.Y.)
|
September 16, 2017
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T Geller, Michal Barzily-Rokni, Tal Danino, et al.
Cancer Immunology Research
|
January 20, 2022
Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16<sup>+</sup> Cancers
Lauren E Colbert, Molly B El, Erica J Lynn, et al.
Cancer Discovery
|
June 16, 2016
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
Pei-Ling Chen, Whijae Roh, Alexandre Reuben, et al.
Cancer Cell
|
May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception
Bo Zhu, Pingjun Chen, Muhammad Aminu, et al.
Nature
|
March 18, 2021
Identification of bacteria-derived HLA-bound peptides in melanoma
Shelly Kalaora, Adi Nagler, Deborah Nejman, et al.
Neuro-Oncology
|
March 22, 2025
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma
Patrick Y Wen, Andrea Manzanera, Caroline Duault, et al.
Nature Communications
|
February 1, 2020
Comprehensive T cell repertoire characterization of non-small cell lung cancer
Alexandre Reuben, Jiexin Zhang, Shin-Heng Chiou, et al.
NPJ Genomic Medicine
|
August 19, 2017
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma
Alexandre Reuben, Christine N Spencer, Peter A Prieto, et al.
Page
of 14